Both in Pharmaceuticals
BlossomHill Therapeutics vs Relmada Therapeutics
Over the past year BLSM returned −40.5% and RLMD returned −15.0%; their daily moves had a correlation of 0.02.
BLSM −40.5% RLMD −15.0%Growth of $1, one year, split-adjusted
| Metric | BLSM | RLMD |
|---|---|---|
| Price | $12.42 | $3.84 |
| Market cap | $394.8M | $409.6M |
| Today | −9.67% | +7.26% |
| 1 month | −36.9% | +6.7% |
| 6 months | — | −48.2% |
| Year to date | — | −20.5% |
| 1 year | — | +65.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | — | $217.7M |
| Dividend yield | — | — |
| Volatility (60d) | — | 58.1% |
| Short % of float | 2.4% | 14.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).